National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Hypercalcemia (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 12/08/2008



Introduction






Overview






Causes






Incidence






Symptoms







Assessment






Treatment






Get More Information From NCI






Changes to This Summary (12/08/2008)






Questions or Comments About This Summary






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Assessment

Laboratory assessment
Clinical assessment
Decision to treat



Laboratory assessment

A blood test is done to check the level of calcium. Other blood tests may be done to check kidney function.

Clinical assessment

Patients with high calcium levels should be examined for the following:

Decision to treat

The decision to treat hypercalcemia depends on the treatment goals determined by the patient, caregivers, and the physician. The natural course of untreated hypercalcemia progresses to loss of consciousness and coma. This may be preferred by some patients at the end of life who have unrelieved suffering and/or untreatable symptoms.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov